Micro Labs Limited — Metformin Exporter Profile
Indian Pharmaceutical Exporter · #7 for Metformin · $16.2M export value · DGFT Verified
Micro Labs Limited is the #7 Indian exporter of Metformin with $16.2M in export value and 552 verified shipments. Micro Labs Limited holds a 3.5% market share in Metformin exports across 31 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Metformin Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Metformin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $10.5M | 375 | 43.7% |
| THAILAND | $2.0M | 57 | 8.2% |
| SLOVAK REPUBLIC | $1.9M | 94 | 8.0% |
| VIETNAM | $1.1M | 24 | 4.5% |
| VIETNAM, DEMOCRATIC REP. OF | $918.6K | 20 | 3.8% |
| PHILIPPINES | $909.7K | 38 | 3.8% |
| HUNGARY | $773.4K | 34 | 3.2% |
| SLOVAKIA | $670.4K | 26 | 2.8% |
| LEBANON | $536.7K | 17 | 2.2% |
| SRI LANKA | $457.4K | 29 | 1.9% |
Micro Labs Limited exports Metformin to 43 countries. The largest destination is FRANCE accounting for 43.7% of Micro Labs Limited's Metformin shipments, followed by THAILAND (8.2%) and SLOVAK REPUBLIC (8.0%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Metformin from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CENTRE SPECIALITES PHARMACEUTIQUES | FRANCE | $10.0M | 322 |
| TEVA PHARMACEUTICAL WORKS PRIVATE | HUNGARY | $2.6M | 124 |
| CENTRAL PHARMACEUTICAL JOINT STOCK | VIETNAM, DEMOCRATIC REP. OF | $1.5M | 33 |
| ATLANTA MEDICARE CO. LTD | THAILAND | $782.3K | 26 |
| TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED | SLOVAKIA | $725.0K | 30 |
| BROWN AND BURK PHILIPPINES INC | PHILIPPINES | $707.0K | 27 |
| ATLANTA MEDICARE CO LIMITED | THAILAND | $579.4K | 15 |
| YMCA | LEBANON | $429.6K | 13 |
| SOHACO TRADING AND PHARMACEUTICAL | VIETNAM, DEMOCRATIC REP. OF | $428.7K | 9 |
| AL-KAWKAB SCIENTIFIC BUREAU | JORDAN | $339.3K | 7 |
Micro Labs Limited supplies Metformin to 104 buyers globally. The largest buyer is CENTRE SPECIALITES PHARMACEUTIQUES (FRANCE), followed by TEVA PHARMACEUTICAL WORKS PRIVATE (HUNGARY) and CENTRAL PHARMACEUTICAL JOINT STOCK (VIETNAM, DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Metformin Export Value and How Much Does Micro Labs Limited Contribute?
India exported $266.5M worth of Metformin through 15,000 shipments from 528 suppliers to 160 countries, serving 1,475 buyers globally. Micro Labs Limited contributes $16.2M to this total, accounting for 3.5% of India's Metformin exports. Micro Labs Limited ships Metformin to 43 countries through 104 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Metformin Exports?
Micro Labs Limited's average Metformin shipment value is $29.4K per consignment, based on 552 shipments totaling $16.2M. The largest destination is FRANCE (43.7% of Micro Labs Limited's Metformin exports).
How Does Micro Labs Limited Compare to Other Indian Metformin Exporters?
Micro Labs Limited ranks #7 among 528 Indian Metformin exporters with a 3.5% market share. The top 3 exporters are GRANULES INDIA LIMITED ($113.9M), ZENTIVA PRIVATE LIMITED ($19.4M), IPCA LABORATORIES LIMITED ($17.1M). Micro Labs Limited processed 552 shipments to 31 destination countries.
What Metformin Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| METFORMINE BIOGARAN 1000 MG, COATED TABL | $537.9K | 15 |
| METFORMIN 500mg TABLETS EU. Batch Nos. M | $475.9K | 21 |
| METFORMIN 850mg TABLETS EU Batch Nos. MG | $455.1K | 15 |
| METFORMIN 1000mg TABLETS EU Batch Nos. M | $433.9K | 16 |
| METFORMINE BGR 500 MG COATED TABLET ( (M | $389.0K | 8 |
| METFORMINE BIOGARAN 1000MG,COATED TABLET | $313.1K | 8 |
| MELMET-500 (METFORMIN TABLETS BP 500MG) | $275.4K | 9 |
| METFORMIN 1000mg TABLETS EU. Batch Nos. | $262.2K | 14 |
| METFORMINE BGR 850 MG COATED TABLET(METF | $242.8K | 7 |
| METFORMINE BGR 850 MG, COATED TABLET(MET | $212.9K | 5 |
Micro Labs Limited exports 878 distinct Metformin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is METFORMINE BIOGARAN 1000 MG, COATED TABL with 15 shipments worth $537.9K.
How Does Micro Labs Limited Compare to Nearest Metformin Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | IPCA LABORATORIES LIMITED | $17.1M | 342 | 14 | $50.0K |
| 3 | INVENTIA HEALTHCARE LIMITED | $16.4M | 329 | 16 | $50.0K |
| 7 | MICRO LABS LIMITED ★ | $16.2M | 552 | 31 | $29.4K |
| 6 | AUROBINDO PHARMA LTD | $14.8M | 296 | 9 | $50.0K |
| 8 | ALKEM LABORATORIES LIMITED | $13.3M | 289 | 4 | $45.9K |
Micro Labs Limited ranks #7 among 528 Indian Metformin exporters. Average shipment value of $29.4K compared to the market average of $504.7K. The closest competitors by value are IPCA LABORATORIES LIMITED and INVENTIA HEALTHCARE LIMITED.
Which Indian Ports Ship Metformin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 2,284 | 15.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,638 | 10.9% |
| HYDERABAD ICD (INSNF6) | 1,593 | 10.6% |
| DELHI AIR CARGO ACC (INDEL4) | 1,355 | 9.0% |
| SAHAR AIR | 1,015 | 6.8% |
| JNPT/ NHAVA SHEVA SEA | 843 | 5.6% |
| DELHI AIR | 711 | 4.7% |
| Bombay Air | 695 | 4.6% |
What Other Diabetes & Endocrine Products Does Micro Labs Limited Export?
Micro Labs Limited also exports these diabetes & endocrine products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Micro Labs Limited's Metformin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Metformin, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Metformin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Metformin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 1,245 individual customs records matching Micro Labs Limited exporting Metformin, covering 878 formulations to 43 countries via 104 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 160+ countries, 1,475+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Metformin Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Metformin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Metformin Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Metformin. For current shipment-level data, contact TransData Nexus.